Sanofi Acquires Shares from L’Oréal in Strategic Buyback

Sanofi has announced the acquisition of 2.3% of its shares from long-time shareholder L’Oréal, as part of its share buyback program. This move aligns with Sanofi's policy for sustainable shareholder value. François Roger, Sanofi's Chief Financial Officer, emphasized the importance of L’Oréal as a partner and the strategic value of this acquisition.

The transaction is structured as an off-market block trade with no special conditions, approved by Sanofi’s Board within the framework of a related-party agreement. Sanofi will purchase 29,556,650 shares at €101.50 each, totaling €3 billion, reflecting a 2.8% discount. These shares will be canceled by April 29, 2025, enhancing Sanofi's earnings per share.

After share cancellation, L’Oréal will hold 7.2% of Sanofi with 13.1% voting rights. Independent expert Finexsi has confirmed the fairness of the transaction, indicating no adverse financial impact on Sanofi.